Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design

In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles

(2017) Anuj Garg et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles

(2017) Antonio Di Martino et al.   JOURNAL OF NANOPARTICLE RESEARCH

A quality by design approach for the development of lyophilized liposomes with simvastatin

(2017) Alina Porfire et al.   SAUDI PHARMACEUTICAL JOURNAL

Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?

(2016) Jie Qu et al.   DRUG DELIVERY

Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery

(2015) Miaojing Wu et al.   DRUG DELIVERY

Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy

(2015) Shuxin Song et al.   DRUG DELIVERY

Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

(2015) Andreas Wicki et al.   JOURNAL OF CONTROLLED RELEASE

Development and Characterization of siRNA Lipoplexes: Effect of Different Lipids, In Vitro Evaluation in Cancerous Cell Lines and In Vivo Toxicity Study

(2014) Nirav Khatri et al.   AAPS PHARMSCITECH

Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea

(2014) So Hyun Bae et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Temozolomide chemical degradation to 5-aminoimidazole-4-carboxamide – Electrochemical study

(2013) Ilanna C. Lopes et al.   JOURNAL OF ELECTROANALYTICAL CHEMISTRY

Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: Preparation, characterization, and pharmacokinetics

(2011) Yan Shen et al.   DRUG DELIVERY

A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment

(2011) Xiaoming Xu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Poly(methyl malate) Nanoparticles: Formation, Degradation, and Encapsulation of Anticancer Drugs

(2011) Alberto Lanz-Landázuri et al.   MACROMOLECULAR BIOSCIENCE

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles

(2010) Chunbai He et al.   BIOMATERIALS

Temozolomide in malignant gliomas: current use and future targets

(2009) J. Lee Villano et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Evaluation of the exposure equivalence of oral versus intravenous temozolomide

(2009) Blanca D. Diez et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

New strategies to deliver anticancer drugs to brain tumors

(2009) Valentino Laquintana et al.   Expert Opinion on Drug Delivery

Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation

(2009) Chiraz Jaafar-Maalej et al.   JOURNAL OF LIPOSOME RESEARCH

Pharmaceutical stability aspects of nanomedicines

(2009) Madaswamy S Muthu et al.   Nanomedicine

Potential of solid lipid nanoparticles in brain targeting

(2008) Indu Pal Kaur et al.   JOURNAL OF CONTROLLED RELEASE

Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model

(2008) Qingyu Zhou et al.   NEURO-ONCOLOGY